News - 14 Sep `20AVITA Medical: clinical trials in the USA

New

First patient enrolled in AVITA Therapeutic’s study in Miami earlier this week. The prospective study is evaluating the RECELL system for repigmentation of patients with stable vitiligo, meaning they have not had new vitiligo lesions or lesions that have expanded for at least one year.

AVITA’s technology creates an autologous suspension from a piece of the patient's own normal skin in under 30 minutes, to spray pigment-producing cells onto vitiligo lesion.

The company is about to begin two multi-center clinical trials in the USA (details 1 and details 2)

For more information, please contact: Elizabeth Kirshner at 661-367-9180 or ekirshner@avitamedical.com

 

      FAQOther Questions

      • Can a gluten-free diet help with vitiligo?

        It's very unlikely. We have specifically looked into claims that gluten-free diet may ease symptoms of vitiligo, or completely reverse it, and found no firm scientific evidence ...

      • Is vitiligo contagious?

        Vitiligo is NOT contagious. It cannot be passed on or caught from touching someone with vitiligo, shaking hands, swimming in the same pool, sharing towels, sitting next to someo...

      • What causes vitiligo?

        Surprisingly, the causes of vitiligo are yet to be precisely established. Researchers know the cause is pre-wired in your genes, just waiting for a bad luck moment. In about hal...